Chartwell Investment Partners, LLC Amarin Corp Plcuk Transaction History

Chartwell Investment Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$4.04 - $5.31 $496,144 - $652,110	-122,808 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$4.78 - $8.26 $124,404 - $214,974	26,026 Added 26.89%	122,808 $850,000
Q1 2020 Apr 30, 2020	SELL	$4.0 - $21.53 $312,360 - $1.68 Million	-78,090 Reduced 44.66%	96,782 $387,000
Q4 2019 Jan 29, 2020	SELL	$13.94 - $24.12 $2.34 Million - $4.05 Million	-167,888 Reduced 48.98%	174,872 $3.75 Million
Q2 2019 Aug 19, 2019	BUY	$16.27 - $20.51 $245,400 - $309,352	15,083 Added 4.6%	342,760 $6.65 Million
Q1 2019 Apr 11, 2019	BUY	$12.61 - $22.33 $1.23 Million - $2.18 Million	97,573 Added 42.4%	327,677 $6.8 Million
Q4 2018 Feb 01, 2019	BUY	$12.41 - $22.98 $2.86 Million - $5.29 Million	230,104 New	230,104 $3.13 Million

156

68.2M

133K

26.4K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $4.24B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.